Valvular disease pertains to a spectrum of conditions impacting the heart valves, integral structures responsible for orchestrating the seamless flow of blood within the heart. These valves—namely, the mitral, aortic, tricuspid, and pulmonary valves—work in harmony to ensure the unidirectional movement of blood. Valvular disorders can manifest in the form of stenosis, characterized by the narrowing of the valve opening, or regurgitation, involving the backflow or leakage of blood. Both scenarios compromise the heart's efficiency in pumping blood, leading to various symptoms and potential complications. Underlying causes of valvular diseases are diverse and can include congenital abnormalities, infectious agents affecting the heart valves, or degeneration associated with aging. The manifestation of symptoms varies, encompassing chest pain, fatigue, and shortness of breath, among others. Early detection and accurate diagnosis through imaging studies and echocardiograms are pivotal in initiating timely and appropriate management strategies.
Title : New mechanisms and innovative therapeutics for pulmonary hypertension
Yong Xiao Wang, Albany Medical Center, United States
Title : STEMI versus acute occlusive myocardial infarction: Which term should we use?
Yochai Birnbaum, Baylor College of Medicine, United States
Title : Preservation of Skeletal Muscle Mass During GLP 1 Receptor Agonist Mediated Weight Loss Clinical Determinants Risk Stratification and Evidence Based Mitigation Strategies
Narendra Kumar, HeartbeatsZ Academy, United Kingdom
Title : A Unique Case of Infective Endocarditis: Staphylococcus lugdunensis Infective Endocarditis Presenting as Embolic Occipital Stroke Due to Posterior Mitral Leaflet Perforation
Nuha Hasnain, Royal Preston Hospital, United Kingdom
Title : New recommendations for the prevention of sudden cardiac death in athletes and recreational sports
Sekib Sokolovic, ASA Hospital Sarajevo, Bosnia and Herzegowina
Title : Coronary revascularization in patients with diabetes: Prospects for stenting in patients with type 1 diabetes and coronary artery disease
Mekhman N Mamedov, National Research Center for Therapy and Preventive Medicine, Russian Federation